Table 2 Levels of CA 19-9 (obtained from Elecsys CA 19-9 Assay) and hydrogen peroxide (calculated after sensing by Te@ZIF-8-GCE) from serum samples of pancreatic cancer patients.

From: Tellurium doped zinc imidazole framework (Te@ZIF-8) for quantitative determination of hydrogen peroxide from serum of pancreatic cancer patients

No.

CA 19-9 (units mL−1)

Current (µA)

Conc. (µM)

Scan rate (mV/s)

Potential (V)

1

3.6

1.05

0.15

0.01

− 0.4 to + 0.8

2

30.0

2.66

0.39

0.01

− 0.4 to + 0.8

3

35.5

7.1

1.04

0.01

− 0.4 to + 0.8

4

67.37

9.8

1.44

0.01

− 0.4 to + 0.8

5

91.2

11.68

1.71

0.01

− 0.4 to + 0.8

6

92.6

16.01

2.35

0.01

− 0.4 to + 0.8

7

189

18.20

2.67

0.01

− 0.4 to + 0.8